Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
09/2003
09/03/2003EP1339426A2 Antibodies that immunospecifically bind to trail receptors
09/03/2003EP0938678B1 Method and kit for the diagnosis of troponin i
09/03/2003EP0927195B1 Process for producing a plasma protein-containing medicament
09/03/2003EP0914614B1 CHARPERONES CAPABLE OF BINDING TO PRION PROTEINS AND DISTINGUISHING THE ISOFORMS PrPc AND PrPsc
09/03/2003EP0857210B1 Therapeutic antiangiogenic compositions and methods
09/03/2003EP0833670B1 Vaccine against rotavirus infection comprising peptides of viral enterotoxin nsp4
09/03/2003EP0765172B1 Cross-reacting monoclonal antibodies specific for e-selectin and p-selectin
09/03/2003EP0751780B1 Methods of isolating cd1-presented antigens, vaccines comprising cd1-presented antigens, and cell lines for use in said methods
09/03/2003EP0737209B1 Metal ion-ligand coordination complexes, antibodies directed thereto, and assays using such antibodies
09/03/2003EP0673425B1 Dna encoding chitin deacetylase
09/03/2003EP0660874B1 Recombinant dnase b derived from streptococcus pyogenes
09/03/2003EP0651646B1 Therapeutic conjugates of toxins and drugs
09/03/2003EP0607297B1 Hormone analogs with multiple ctp extensions
09/03/2003CN1440462A Method of identifying and producing antigen peptides and use thereof as vaccines
09/03/2003CN1440456A Sentinel virus Ôàí"
09/03/2003CN1440424A Antibody selective for tumor necrosis factor-related apoptosis-inducing ligand receptor and use thereof
09/03/2003CN1440420A Methods for preventing neural tissue damage and for the treatment of alpha-synuclein diseases
09/03/2003CN1440419A Compounds and methods for treatment and prevention of bacterial infection
09/03/2003CN1439651A Recombined human CD11a monoclone antibody and its preparation and medicinal composition
09/03/2003CN1439650A Preparation of multi-antigen from waterfowl
09/02/2003US6613894 Bonding the nucleoside to a solid support, deprotecting using an acid, reacting with a nucleoside phosphoramidite; oxidizing and coupling a biomolecule to the product
09/02/2003US6613891 Polynucleotides that encode bovine inhibin
09/02/2003US6613886 Antibodies that specifically bind a Bacillus thuringiensis toxin receptor
09/02/2003US6613746 Cell adhesion proteins having cells with glycoprotein antibodies and carbohydrate determinants used to interfere with binding FC receptor and as complement inhibitors; antiinflammatory agents
09/02/2003US6613564 Enzyme-protein complex
09/02/2003US6613563 Viral vectors with modified tropism
09/02/2003US6613557 Recombinant DNA molecules which encode viral protein; transfecting a host cell with the DNA molecules; used for diagnostic purposes or for incorporation in a vaccine
09/02/2003US6613546 DNA; genomes; axons; exons; introns; splicing/genetic/; use to produce "useful protein" by animal cells transformed with expression vector comprised of nucleic acid encoding the "useful protein" and linked to DNA having promoter activity
09/02/2003US6613544 Osteoprotegerin
09/02/2003US6613538 Detection of HLA-G
09/02/2003US6613537 Diagnosis of diabetes
09/02/2003US6613536 Complementarity-determining region; monoclonal antibodies; antiidiotypic antibodies; autoantibodies; heavy chains; light chains; polypeptides; amino acid sequences; DNA; carriers; use for treatment of systemic lupus erythematosus in humans
09/02/2003US6613532 Anti-lamin antibodies, endogeneous inhibitors of thrombosis
09/02/2003US6613521 Nucleic acids; CARD (Caspase Recruitment Domain) proteins; primers; hybridization probes; use in diagnosis, therapy for disorders from with abnormal levels of apoptotic cell death or abnormal activity of FAS/APO-1 or TNF receptor complexes
09/02/2003US6613514 Evolving preferential protein; digest nuclelotide sequences substrate, join terminals, screen for preferential proteins, recover nucleotide sequences
09/02/2003US6613331 Vaccine against Lyme disease
09/02/2003US6613329 Vaccine and antitoxin for treatment and prevention of C. difficile disease
09/02/2003US6613328 Methods of treating thrombotic diseases with von Willebrand factor specific antibodies
09/02/2003US6613327 Methods of preventing immune-mediated abortion by inhibiting a CD28-mediated costimulatory signal
09/02/2003US6613326 Antitoxins and methods for making antitoxins
09/02/2003US6613322 Administering enzyme inhibitors
09/02/2003CA2151543C Immunogens for the production of cocaine-hydrolyzing catalytic antibodies
08/2003
08/28/2003WO2003070981A2 Seequences specifically deleted mycobacterium tuberculosis genome and their use in diagnostics and as vaccines
08/28/2003WO2003070933A2 Process of cell electrofusion
08/28/2003WO2003070899A2 Phospho-specific antibodies to flt3 and uses thereof
08/28/2003WO2003070894A2 A non-invasive diagnostic test utilizing histone modification markers
08/28/2003WO2003070889A2 Prostate specific genes and the use thereof in design or therapeutics
08/28/2003WO2003070882A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and used thereof
08/28/2003WO2003070771A1 Rrp sequences and knockout mice and uses thereof
08/28/2003WO2003070768A2 Cd40 splice variants,method of detection thereof, compositions comprising said variant(s) or nucleic acid encoding the same and use thereof
08/28/2003WO2003070760A2 Anti-amyloid beta antibodies and their use
08/28/2003WO2003070752A2 Mhc-peptide complex binding ligands
08/28/2003WO2003070275A1 Use of an inhibitor or antagonist against tissue factor
08/28/2003WO2003070274A1 The use of tnf-alpha antagonist as drugs for the treatment of patients with sepsis and without suffering from total organ failure
08/28/2003WO2003070192A2 Compositions and methods for surrogate antibody modulation of an immune response and transport
08/28/2003WO2003070190A2 Surrogate antibodies and methods of preparation and use thereof
08/28/2003WO2003055911A3 Cystine-knot fold protein
08/28/2003WO2003041731A3 Method to obtain protection against bystander allergen
08/28/2003WO2003028840A3 Combined compositions and methods for tumor vasculature coagulation and treatment
08/28/2003WO2003025018A3 Dimeric and multimeric antigen binding structure
08/28/2003WO2003025015A3 A soluble toll-like receptor
08/28/2003WO2003020757A3 Novel genetic products obtained from ashbya gossypii, which are associated with transcription mechanisms, rna processing and/or translation
08/28/2003WO2003018631A3 Nogo receptor homologues and their use
08/28/2003WO2003014161A3 Antigen binding domains from fish
08/28/2003WO2003014153A3 Cellular virus receptors and methods of use.
08/28/2003WO2002102990A3 Fibroblast growth factor and nucleic acid encoding same
08/28/2003WO2002102837A3 Marker for identifying hematopoietic stem cells
08/28/2003WO2002100248A3 Compositions and methods relating to glucose metabolism, weight control, and food intake
08/28/2003WO2002097044A3 Alternative splice forms of proteins as basis for multiple therapeutic modalities
08/28/2003WO2002094192A3 Antibodies against tumor necrosis factor delta (april)
08/28/2003WO2002083720A3 Intermediates and enzymes of the non-mevalonate isoprenoid pathway
08/28/2003WO2002081508A3 Use of cd25 binding molecules in steroid-resistant patients
08/28/2003WO2002077021A3 Streptococcus pneumoniae proteins and nucleic acids
08/28/2003WO2002074337A8 Hmgb1 protein inhibitors and/or antagonists for the treatment of vascular diseases
08/28/2003WO2002068687A3 Function and application of tob gene in central nervous system of mammal
08/28/2003WO2002044736A3 Diagnosis and treatment of epidermal or skin diseases
08/28/2003WO2002043478A3 Transgenic transchromosomal rodents for making human antibodies
08/28/2003WO2002036627A3 Interferons, uses and compositions related thereto
08/28/2003WO2002034940A3 Methods for screening compounds that modulate lipid metabolism
08/28/2003WO2002034922A3 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof
08/28/2003WO2002029097A3 Methods relating to polymorphisms in the human gpr10 gene
08/28/2003WO2002018948A3 Differentially expressed epitopes and uses thereof
08/28/2003WO2002012470A3 A member of the lysyl oxidase gene family
08/28/2003WO2002008399A3 Human kinases
08/28/2003WO2002002780A3 Human serine-threonine kinase
08/28/2003WO2001092307A3 Therapeutic compounds for ovarian cancer
08/28/2003US20030162954 Antitumor agents; gastrointestinal disorders
08/28/2003US20030162948 Tumour necrosis factor binding ligands
08/28/2003US20030162947 Rapid production of monoclonal antibodies
08/28/2003US20030162946 Isolated human G-protein coupled receptors, nucleic acid molecules encoding human GPCR proteins, and uses thereof
08/28/2003US20030162944 Nucleic acid encoding neuropeptide Y/peptide YY (Y2) receptors and uses thereof
08/28/2003US20030162737 Preventives and remedies for pulmonary hypertension
08/28/2003US20030162714 Modulate cell differentiation; muscular disorders; fat metabolism; bone disorders
08/28/2003US20030162709 Methods of generating multispecific, multivalent agents from VH and VL domains
08/28/2003US20030162278 Use for development of human therapeutic proteins; amino acid sequences, allelic variants, isolated polypeptide, antibody and nucleic acids, transgenic non-human animal, culturing the host cell, genetic engineering
08/28/2003US20030162274 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
08/28/2003US20030162263 Specific peptide of 6 to 40 amino acids and is capable of giving rise to antibodies which inhibit superantigen activity associated with HERV-K18 (human endogenous retrovirus) localized in intron 1 of CD48 gene on chromosome 1
08/28/2003US20030162256 PTH1R and PTH3R receptors, methods and uses thereof
08/28/2003US20030162252 Isolating cDNAs encoding novel G protein-coupled receptor proteins derived from human spleen
08/28/2003US20030162250 Secreted and transmembrane polypeptides and nucleic acids encoding the same
1 ... 891 892 893 894 895 896 897 898 899 900 901 902 903 904 905 906 907 908 909 910 911 ... 1494